Myopia, or nearsightedness, is a global epidemic with prevalence rates in Canadian children increasing at an alarming rate.

According to the World Health Organization, occurrences of myopia (nearsightedness) are expected to increase from approximately two billion people in 2010 to nearly five billion people in 2050 – that’s almost half of the world’s expected population.

Almost one-third of all cases of nearsightedness in Canadian children go undiagnosed or untreated. If not properly treated by an Eye Care Professional, nearsightedness can lead to long-term vision complications such as retinal degeneration and detachment.

There’s help! Millions of children across Canada are poised to benefit from a Health Canada approved breakthrough therapy that addresses nearsightedness.

MiSight® 1 day by CooperVision® is the world’s first 1-day soft contact lens proven to slow myopia progression in children by 59 percent.¹*

To learn more about myopia (nearsightedness), its signs, contributing factors, treatment options and to find a trusted Eye Care Professional near you, visit Fight Myopia.



Sources:

1. Chamberlain P, Logan N, Jones D, Gonzalez-Meijome J, Saw S-M, Young G. Clinical evaluation of a dual-focus myopia control 1 day soft contact lens: 3-year results. Presented at: British Contact Lens Association Clinical Conference, Liverpool, England.

*Compared with a single-vision, one-day lens over a three-year period. Individual results may vary. Data on file, CooperVision.